Pathogenesis of Chagas Disease in Humans
| dc.contributor.author | María‐Jesús Pinazo | |
| dc.contributor.author | Faustino Torrico | |
| dc.contributor.author | Joaquím Gascón | |
| dc.coverage.spatial | Bolivia | |
| dc.date.accessioned | 2026-03-22T21:08:40Z | |
| dc.date.available | 2026-03-22T21:08:40Z | |
| dc.date.issued | 2015 | |
| dc.description | Citaciones: 1 | |
| dc.description.abstract | Chagas disease, or American trypanosomiasis, is a zoonotic disease originally from Latin America, caused by the parasite Trypanosoma cruzi (T. cruzi). Migration has been a key factor in the dissemination of Chagas disease. This chapter presents a brief summary of the most important means of transmission of Chagas disease including vector transmission, transfusion transmission, maternal-fetal transmission, and oral transmission. T. cruzi infection presents with two phases, namely, an acute phase and a chronic phase. The chapter describes both stages of the disease from three points of view: clinical aspects of the infection and/or disease; diagnosis; and treatment and management of people in each stage of the disease. The treatment of Chagas disease should be focused on two aspects: antiparasitic treatment in order to eradicate the parasite, and management of organ involvement due to the disease. | |
| dc.identifier.doi | 10.1002/9781118644843.ch19 | |
| dc.identifier.uri | https://doi.org/10.1002/9781118644843.ch19 | |
| dc.identifier.uri | https://andeanlibrary.org/handle/123456789/86191 | |
| dc.language.iso | en | |
| dc.source | Universitat de Barcelona | |
| dc.subject | Chagas disease | |
| dc.subject | Trypanosoma cruzi | |
| dc.subject | Disease | |
| dc.subject | Transmission (telecommunications) | |
| dc.subject | Trypanosomiasis | |
| dc.subject | Immunology | |
| dc.subject | Pathogenesis | |
| dc.subject | Vector (molecular biology) | |
| dc.subject | Virology | |
| dc.subject | Parasitic disease | |
| dc.title | Pathogenesis of Chagas Disease in Humans | |
| dc.type | other |